PLOSopen access
Precision oncology’s translation gap—Can molecular tumor boards bridge it?
next-generation sequencing, next-generation sequencing, cancer genomics, next-generation sequencing, mycobacterium tuberculosis, oncology
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 327599
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.